Enveric Biosciences, Inc.

Enveric Biosciences, Inc. - PE Ratioverified

ENVB

Price:

$1.28

Market Cap:

$764.17K

Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alongside EV102, a cannabinoid cream formulated for topical skin application. Rounding out their portfolio is EV101, a novel combination therapy integrating cannabinoids with chemotherapy. This innovative company is based in Naples, Florida.

Industry

Biotechnology

IPO Date

2015-05-04

Stock Exchange

NASDAQ

Ticker

ENVB

The PE Ratio as of June 2026 (TTM) for Enveric Biosciences, Inc. (ENVB) is -0.06

According to Enveric Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.06. This represents a change of -79.60% compared to the average of -0.29 of the last 4 quarters.

Enveric Biosciences, Inc. (ENVB) Historical PE Ratio (quarterly & annually)

How has ENVB PE Ratio performed in the past?

The mean historical PE Ratio of Enveric Biosciences, Inc. over the last ten years is -64.26. The current -0.06 PE Ratio has changed -90.66% with respect to the historical average. Over the past ten years (40 quarters), ENVB's PE Ratio was at its highest in in the September 2022 quarter at 58.61. The PE Ratio was at its lowest in in the September 2019 quarter at -531.88.

Quarterly (TTM)
Annual

Average

-64.26

Median

-5.50

Minimum

-458.81

Maximum

-0.10

Enveric Biosciences, Inc. (ENVB) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Enveric Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 768.37%

Maximum Annual PE Ratio = -0.10

Minimum Annual Increase = -95.20%

Minimum Annual PE Ratio = -458.81

Quarterly (TTM)
Annual
YearPE RatioChange
2025-0.10-64.55%
2024-0.28-88.28%
2023-2.41-43.53%
2022-4.27-36.55%
2021-6.73-88.31%
2020-57.5780.00%
2019-31.98768.37%
2018-3.68-95.20%
2017-76.76-83.27%
2016-458.81-20.65%

Enveric Biosciences, Inc. (ENVB) Average PE Ratio

How has ENVB PE Ratio performed in the past?

The current PE Ratio of Enveric Biosciences, Inc. (ENVB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.93

5-year avg

-2.76

10-year avg

-64.26

Enveric Biosciences, Inc. (ENVB) PE Ratio vs. Peers

How is ENVB’s PE Ratio compared to its peers?

Enveric Biosciences, Inc.’s PE Ratio is greater than Jasper Therapeutics, Inc. (-0.13), greater than Onconetix, Inc. (-0.11), less than ZyVersa Therapeutics, Inc. (-0.06), greater than Indaptus Therapeutics, Inc. (-0.62), less than SciSparc Ltd. (-0.03), greater than Azitra, Inc. (-0.07), less than Silexion Therapeutics Ltd. (0.06), less than Scinai Immunotherapeutics Ltd. (0.00), greater than Salarius Pharmaceuticals, Inc. (-0.19), greater than Hepion Pharmaceuticals, Inc. (-0.23),

Build a custom stock screener for Enveric Biosciences, Inc. (ENVB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Enveric Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Enveric Biosciences, Inc. (ENVB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Enveric Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Enveric Biosciences, Inc.'s PE Ratio?

How is the PE Ratio calculated for Enveric Biosciences, Inc. (ENVB)?

What is the highest PE Ratio for Enveric Biosciences, Inc. (ENVB)?

What is the 3-year average PE Ratio for Enveric Biosciences, Inc. (ENVB)?

What is the 5-year average PE Ratio for Enveric Biosciences, Inc. (ENVB)?

How does the current PE Ratio for Enveric Biosciences, Inc. (ENVB) compare to its historical average?